XBiotech Inc.

NASDAQ:XBIT

Biotechnology

Healthcare
$1.73 -0.84%

-$0.02 today

Market cap
$52.74M
Beta
0.84
P/E (TTM)
-1.8
EPS (TTM)
-$1.32
52W Low $2.09High $3.61

Volume 0.06M

Average 0.03M

XBIT Total Assets

Everything the company owns or controls; equal to total liabilities plus equity.

XBiotech Inc.NASDAQ: XBIT

Total Assets · Q1 FY2026 · quarter ended Mar 2026

Total assets falls 23.1% from a year ago

Total assets stood at $139.84M at the end of Q1 FY2026, down 23.1% from a year earlier and down 6.8% from the prior quarter. Over 3 fiscal years it compounded at -15.2% a year.

Context

  • Total assets increased in 0 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether total assets keeps falling in the next quarterly balance sheet after a -23.1% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$139.84M-6.8% QoQ
Last fiscal yearDec 2025
$150.08M-24.6% YoY
Year agoMar 2025
$181.86M-23.1% since
Total Assets past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-23.1%——
1 year-24.6%——
3-year CAGR-15.2%——
5-year CAGR——
10-year CAGR——

Total Assets history

USD · from the balance sheet

Latest · FY2025
150.08M USD
Year-over-year change
-24.6%
4-year CAGR
-14.1%

Total Assets vs competitors

How XBIT compares with its peers on the latest reported figures

  • XBIT's Mar 2026 total assets of $139.84M is the 5th highest of the 9 companies compared; the peer median is $138.61M.
  • Its year-over-year change of -23.1% is the 7th highest of 9, against a peer median of +0.3%.
  • Over three fiscal years its annual growth of -15.2% compares with a peer median of -12.4%.
XBIT Competitors Peer median
Total Assets for XBIT and competitors
Company Period Latest balance YoY 3-year CAGR
FBIOFortress Biotech, Inc.Mar 2026$356.87M +100.4%-14.3%
RLMDRelmada Therapeutics, Inc.Mar 2026$235.36M +750.3%-15.0%
TCRXTScan Therapeutics, Inc.Mar 2026$201.99M -39.3%+4.7%
ACETAdicet Bio, Inc.Mar 2026$169.38M -11.4%-16.5%
XBITXBiotech Inc.Mar 2026$139.84M -23.1%-15.2%
ACRVAcrivon Therapeutics, Inc. Common StockMar 2026$107.83M -38.9%-10.5%
ADAGAdagene Inc.Dec 2025$78.26M -12.3%-19.9%
GANXGain Therapeutics, Inc.Mar 2026$18.74M +61.2%-1.8%
NTRBNutriband Inc.Apr 2026$6.89M +12.0%-7.2%
Peer median (excluding XBIT) $138.61M+0.3%-12.4%

Competitors are the stored peer set for XBIT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents236.98M157.31M200.02M172.68M125.55M
Short-term Investments060.17M000
Net Receivables8.95M1.76M935K858K360K
Inventory00000
Other Current Assets0601K760K1.03M1.04M
Total Current Assets246.87M219.84M201.72M174.57M126.95M
Property, Plant & Equipment (Net)28.31M26.26M24.9M24.53M23.13M
Goodwill00000
Intangible Assets00000
Long-term Investments00000
Tax Assets1.09M1.66M000
Other Non-current Assets(1.09M)(1.66M)000
Total Non-current Assets28.31M26.26M24.9M24.53M23.13M
Total Assets275.18M246.1M226.62M199.09M150.08M
Account Payables2.07M2.41M2.52M2.22M1.54M
Short-term Debt00010.25M0
Tax Payables10K55K83K1.72M76K
Deferred Revenue00000
Other Current Liabilities904K1.17M562K611K5.18M
Total Current Liabilities3.45M4.07M6.1M15.11M7.93M
Long-term Debt00000
Deferred Tax Liabilities873K59K005K
Deferred Revenue (Non-current)00000
Other Non-current Liabilities1.47M1.58M1.67M1.72M1.8M
Total Non-current Liabilities2.34M1.64M1.67M1.72M1.8M
Total Liabilities5.79M5.7M7.77M16.83M9.73M
Common Stock262.26M267.33M271.15M273.11M276.73M
Retained Earnings5.15M(27.75M)(52.31M)(90.84M)(136.38M)
Accumulated OCI1.97M826K000
Other Stockholders Equity00000
Minority Interest00000
Total Equity269.39M240.4M218.85M182.27M140.35M
Total Debt00010.25M0
Net Debt(236.98M)(157.31M)(200.02M)(162.43M)(125.55M)

XBiotech Inc.

NASDAQ:XBIT

Intrinsic Alpha fair value

Locked

Current Price

$1.73

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.